A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on: February 03,2024 15

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on:February 03,2024 15

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on: January 29,2024 15

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on:January 29,2024 15

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024 18

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024 18

An AI model reveals how the body's defense system recognizes skin cancer

byUniversity of HelsinkiMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaResearchers from the University of Helsinki, HUS Comprehensive Cancer Center, A

Updated on: January 02,2024 9

An AI model reveals how the body's defense system recognizes skin cancer

byUniversity of HelsinkiMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaResearchers from the University of Helsinki, HUS Comprehensive Cancer Center, A

Updated on:January 02,2024 9

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on: January 22,2024 20

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on:January 22,2024 20

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on: June 28,2024 5

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on:June 28,2024 5

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on: April 01,2024 13

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on:April 01,2024 13

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Updated on: March 06,2024 13

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Updated on:March 06,2024 13

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Updated on: April 14,2024 18

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Updated on:April 14,2024 18

Researchers identify a possible therapeutic target for Kennedy´s disease and prostate cancer

by Institute for Research in Biomedicine (IRB Barcelona)Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei.Xavier Salvatella, IRB Barcel

Updated on: June 06,2024 5

Researchers identify a possible therapeutic target for Kennedy´s disease and prostate cancer

by Institute for Research in Biomedicine (IRB Barcelona)Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei.Xavier Salvatella, IRB Barcel

Updated on:June 06,2024 5

Better cancer treatment inspired by the foam on your latte

by Jennifer Brown,University of IowaSchematic diagram illustrating how O2-GeMs are fabricated and incorporated into clinically relevant therapies for treatment-refractory tumors, such as MPNSTs.

Updated on: January 02,2024 10

Better cancer treatment inspired by the foam on your latte

by Jennifer Brown,University of IowaSchematic diagram illustrating how O2-GeMs are fabricated and incorporated into clinically relevant therapies for treatment-refractory tumors, such as MPNSTs.

Updated on:January 02,2024 10

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024 13

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024 13